|
Full bibliography available here
EJVES, European Journal of Vascular & Endovascular Surgery, May 2012
Gage SM, Katzman HE, Ross JR, Hohmann SE, Sharpe CA, Butterly DW, Lawson JH. Multi-center Experience of 164 Consecutive Hemodialysis Reliable Outflow (HeRO) Graft Implants for Hemodialysis Treatment.
Journal of Surgical Research, May 2012
Dageforde LA, Bream PR, Moore DE. Hemodialysis Reliable Outflow (HeRO) device in end-stage dialysis access: A decision analysis model.
JVS, Journal of Vascular Surgery, May 2012
Allan BJ, Prescott AT, Tabbara, M, Bornak A, Goldstein LJ. Modified use of the Hemodialysis Reliable Outflow (HeRO) graft for salvage of threatened dialysis access.
National Kidney Foundation Clinical Bulletin, January 2012
A Clinical Update on an Alternative Vascular Access for the Catheter-Dependent Hemodialysis.
EJVES, European Journal of Vascular & Endovascular Surgery, July 2011
G.J. Chen, J.E. Anaya-Ayala, C.J. Smolock, M.G. Davies and E.K. Peden. Successful Use of the HeRO Device to Salvage a Functional Arteriovenous Fistula and Resolve Symptoms of Venous Hypertension.
Seminars in Vascular Surgery, June 2011
Marc Glickman, MD. HeRO Vascular Access Device.
JVS, Journal of Vascular Surgery, June 2011
Earl Schuman, MD and Amy Ronfeld, RN. Early Use Conversion of the HeRO Dialysis Graft.
Annals of Vascular Surgery, April 2011
Shawn M. Gage, Hardeep S. Ahluwalia and Jeffrey H. Lawson. Salvaging Vascular Access and Treatment of Severe Limb Edema: Case Reports on the Novel Use of the Hemodialysis Reliable Outflow Vascular Access Device.
Nephrology News & Issues, August 2010
Results of a customer-based, post-market surveillance survey of the HeRO access device. Nephrology News & Issues. Vol. 24, No. 9, 30-33 available at www.nephronline.com
An informal quantitative phone survey for 65 HeRO patients was performed via 38 dialysis units in October 2009. Results support earlier HeRO clinical findings, which continue to be favorable for infection rates compared to tunneled dialysis catheters and occlusive events compared to grafts. Q&A
56 Month Follow-Up: Seminars in Dialysis, March/April 2010
George Nassar, MD. Long-Term Performance of the Hemodialysis Reliable Outflow (HeRO) Device: The 56-Month Follow-Up of the First Clinical Trial Patient
Vascular and Endovascular Surgery, January 2010
Julio Vasquez, MD; et. al. Percutaneous Endovascular Management of Occluded HeRO Dialysis Access Device.
JVS, Journal of Vascular Surgery, September 2009
Howard E. Katzman, Robert B. McLafferty, John R. Ross, Marc H. Glickman, Eric K. Peden and Jeffrey H. Lawson. Initial Experience and Outcome of a New Hemodialysis Access Device for Catheter-Dependent Patients.
Nephrology News & Issues, February 2009
Lesley Dinwiddie, MSN, RN, FNP, CNN published product review. Do access-challenged patients need a HeRO?
Endovascular Today, February 2009
Bart Dolmatch, MD, Jack Work, MD, Ingemar Davidson, MD, PHD, published article. A Roundtable on Chronic Dialysis.
|
INDICATIONS FOR USE: The HeRO Graft is indicated for end stage renal disease patients on hemodialysis who have exhausted all other access options. Rx Only. See instructions for use for full indication, contraindication and caution statements. Terms and Conditions. Privacy Policy. HeRO is a Hemosphere, Inc. product distributed by CryoLife, Inc. HeRO, Hemosphere, CryoLife, ‘Life Restoring Technologies’, and the snowflake symbol are trademarks owned by CryoLife, Inc. or its subsidiaries. All other trademarks are owned by their respective companies. © 2012 CryoLife, Inc. All Rights Reserved.